Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CASH FLOWS

v2.4.0.6
CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2010
Cash flows from operating activities:      
Net income $ 76,133 $ 81,168 $ 70,409
Adjustments to reconcile net income to net cash provided by operating activities:      
(Income) loss from discontinued operations (34) 974 (1,012)
Depreciation and amortization 26,460 22,845 18,340
Deferred income taxes (3,274) 1,758 (3,172)
Deferred interest income on note receivable     263
Non-cash equity based compensation 12,077 9,485 7,918
Changes in assets and liabilities, net of effects of business combinations and divestitures:      
Accounts receivable-billed (7,213) (11,584) 38
Accounts receivable-unbilled 2,214 10,068 2,415
Prepaid expenses and other current assets (6,018) (2,573) (1,740)
Deferred contract costs (1,221) (1,309) 1,541
Accounts payable and accrued liabilities 6,485 7,312 (407)
Accrued compensation and benefits (2,648) 4,490 7,883
Deferred revenue 9,827 (11,779) 31,294
Income taxes 6,885 (10,814) 6,374
Other assets and liabilities (4,513) (2,456) 827
Cash provided by operating activities-continuing operations 115,160 97,585 140,971
Cash used in operating activities-discontinued operations   (725) (2,530)
Cash provided by operating activities 115,160 96,860 138,441
Cash flows from investing activities:      
Acquisition of businesses, net of cash acquired (66,003)   (11,960)
Purchases of property and equipment (18,369) (18,506) (13,936)
Capitalized software costs (4,779) (7,608) (8,672)
Proceeds from sales of discontinued operations 2,240   1,700
Proceeds from note receivable 299 237 473
Cash used in investing activities-continuing operations (86,612) (25,877) (32,395)
Cash used in investing activities (86,612) (25,877) (32,395)
Cash flows from financing activities:      
Cash dividends paid (12,180) (10,327) (8,375)
Repurchases of common stock (12,977) (56,540) (40,217)
Employee stock transactions 1,977 8,980 2,763
Tax benefit due to option exercises and restricted stock units vesting 7,268 6,996 2,901
Issuance of long-term debt   304 533
Repayment of long-term debt (44)   (7)
Acquisition-related contingent consideration (1,809) (1,021)  
Cash used in financing activities (17,765) (51,608) (42,402)
Effect of exchange rate changes on cash 5,579 (1,746) 3,862
Net increase (decrease) in cash and cash equivalents 16,362 17,629 67,506
Cash and cash equivalents, beginning of period 172,950 155,321 87,815
Cash and cash equivalents, end of period $ 189,312 $ 172,950 $ 155,321